Literature DB >> 26718172

Minimal Transplant Survival Benefit for Hepatocellular Carcinoma: Is it Real or an Overestimation of Waitlist Life Expectancy?

Neil Mehta1, Julie Heimbach2, Ryutaro Hirose3, John P Roberts3, Francis Y Yao4.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26718172     DOI： 10.1053/j.gastro.2015.08.059

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  2 in total

1.  Comparison of two equivalent model for end-stage liver disease scores for hepatocellular carcinoma patients using data from the United Network for Organ Sharing liver transplant waiting list registry.

Authors:  Sarah K Alver; Douglas J Lorenz; Kenneth Washburn; Michael R Marvin; Guy N Brock
Journal:  Transpl Int       Date:  2017-08-23       Impact factor: 3.782

2.  Survival Benefit of Liver Transplantation for Hepatocellular Carcinoma.

Authors:  Mounika Kanneganti; Nadim Mahmud; David E Kaplan; Tamar H Taddei; David S Goldberg
Journal:  Transplantation       Date:  2020-01       Impact factor: 5.385
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.